List of Excipients in API eslicarbazepine acetate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing eslicarbazepine acetate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Sumitomo Pharma America Inc | APTIOM | eslicarbazepine acetate | 63402-202 | CROSCARMELLOSE SODIUM | |
| Sumitomo Pharma America Inc | APTIOM | eslicarbazepine acetate | 63402-202 | MAGNESIUM STEARATE | |
| Sumitomo Pharma America Inc | APTIOM | eslicarbazepine acetate | 63402-202 | POVIDONE K30 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing eslicarbazepine acetate
Detailed excipient profiles for eslicarbazepine acetate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
eslicarbazepine acetate drug variants containing CELLULOSE, MICROCRYSTALLINE
eslicarbazepine acetate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | eslicarbazepine acetate | 31722-428 |
| Sumitomo Pharma America Inc | eslicarbazepine acetate | 63402-202 |
| Lupin Pharmaceuticals Inc | eslicarbazepine acetate | 68180-290 |
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
eslicarbazepine acetate drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | eslicarbazepine acetate | 67877-585 |
| >Company | >Ingredient | >NDC |
eslicarbazepine acetate drug variants not containing COPOVIDONE K25-31
Excipient focus: CROSCARMELLOSE SODIUM
eslicarbazepine acetate drug variants containing CROSCARMELLOSE SODIUM
eslicarbazepine acetate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
eslicarbazepine acetate drug variants containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | eslicarbazepine acetate | 31722-428 |
| >Company | >Ingredient | >NDC |
eslicarbazepine acetate drug variants not containing GLYCERYL MONOSTEARATE
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
eslicarbazepine acetate drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | eslicarbazepine acetate | 68180-290 |
| >Company | >Ingredient | >NDC |
eslicarbazepine acetate drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: HYPROMELLOSE
eslicarbazepine acetate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | eslicarbazepine acetate | 43598-684 |
| >Company | >Ingredient | >NDC |
eslicarbazepine acetate drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
eslicarbazepine acetate drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | eslicarbazepine acetate | 68180-290 |
| >Company | >Ingredient | >NDC |
eslicarbazepine acetate drug variants not containing HYPROMELLOSE 2910
Excipient focus: LACTOSE MONOHYDRATE
eslicarbazepine acetate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | eslicarbazepine acetate | 68180-290 |
| >Company | >Ingredient | >NDC |
eslicarbazepine acetate drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
eslicarbazepine acetate drug variants containing MAGNESIUM STEARATE
eslicarbazepine acetate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | eslicarbazepine acetate | 31722-428 |
| Ascend Laboratories LLC | eslicarbazepine acetate | 67877-585 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
eslicarbazepine acetate drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | eslicarbazepine acetate | 13668-538 |
| Camber Pharmaceuticals Inc | eslicarbazepine acetate | 31722-428 |
| Sumitomo Pharma America Inc | eslicarbazepine acetate | 63402-202 |
| >Company | >Ingredient | >NDC |
eslicarbazepine acetate drug variants not containing POVIDONE K30
Excipient focus: POVIDONE K90
eslicarbazepine acetate drug variants containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | eslicarbazepine acetate | 31722-428 |
| >Company | >Ingredient | >NDC |
eslicarbazepine acetate drug variants not containing POVIDONE K90
Excipient focus: SILICON DIOXIDE
eslicarbazepine acetate drug variants containing SILICON DIOXIDE
eslicarbazepine acetate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | eslicarbazepine acetate | 31722-428 |
| DrReddys Laboratories Inc | eslicarbazepine acetate | 43598-684 |
| Sumitomo Pharma America Inc | eslicarbazepine acetate | 63402-202 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
eslicarbazepine acetate drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | eslicarbazepine acetate | 31722-428 |
| Ascend Laboratories LLC | eslicarbazepine acetate | 67877-585 |
| >Company | >Ingredient | >NDC |
eslicarbazepine acetate drug variants not containing SODIUM STEARYL FUMARATE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
